Novartis gets FDA ok for sickle-cell drug
Novartis announced it won U.S. FDA approval for its experimental sickle cell disease drug, Adakveo.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Sickle Cell Anemia